Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria
Completed · Phase 2 · Has a placebo group
Conditions studied: Hyperuricemia, Albuminuria, Type 2 Diabetes
In brief
The purpose of this clinical research study is to evaluate signals of potential clinical benefit of the combination of Verinurad and Febuxostat in lowering concentrations of circulating uric acid and thus improving kidney or cardiovascular status of patients with hyperuricemia, albuminuria, and Type 2 diabetes (T2DM).
Key facts
- Study ID
- NCT03118739
- Run by
- AstraZeneca
- People needed
- 60
- Starts
- 2017-05-18
- Expected to finish
- 2018-08-13
- Last updated by the study team
- 2020-01-10
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Serum Uric Acid ≥6.0 mg/dL
- eGFR ≥30 mL/min/1.73 m2
- UACR between 30 mg/g and 3500 mg/g inclusive
- Diagnosed with T2DM
You may not qualify if…
- Treated with any drug for hyperuricemia in the 6 months preceding randomization.Drugs for hyperuricemia include all XO inhibitors (allopurinol, febuxostat and topiroxostat) and URAT1 inhibitors (lesinurad, verinurad, probenecid, and benzbromarone)
- Prior history of gout, unless prophylaxis therapy isn't required
- Patients who are pregnant, lactating, or planning to become pregnant
- Patients unsuitable or unable to undergo MRI assessment
Where it is running
- Research Site — Canyon Country, California, United States
- Research Site — Chula Vista, California, United States
- Research Site — Corona, California, United States
- Research Site — Escondido, California, United States
- Research Site — Lakewood, California, United States
- Research Site — Lincoln, California, United States
- Research Site — Los Angeles, California, United States
- Research Site — Los Angeles, California, United States
- Research Site — Los Angeles, California, United States
- Research Site — North Hollywood, California, United States
- Research Site — Oceanside, California, United States
- Research Site — Orange, California, United States
- Research Site — Sacramento, California, United States
- Research Site — Houston, Texas, United States
- Research Site — Houston, Texas, United States
- Research Site — Pearland, Texas, United States
- Research Site — Sugar Land, Texas, United States
- Research Site — Webster, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.